1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porters Fiver Forces Analysis 42
3 Segmentation of North America Market by Offering 46
3.1 Market Overview by Offering 46
3.2 CRISPR Products 48
3.2.1 Kits & Enzymes 50
3.2.2 Databases & Libraries 51
3.2.3 Design Tools 52
3.2.4 Antibodies 53
3.2.5 CRISPR Plasmid & Vector 54
3.2.6 Other Products 55
3.3 CRISPR Services 56
3.3.1 gRNA Design & Vector Construction 58
3.3.2 Cell Line Engineering 59
3.3.3 Microbial Gene Editing 60
3.3.4 DNA Synthesis 61
3.3.5 Other Services 62
4 Segmentation of North America Market by Application 63
4.1 Market Overview by Application 63
4.2 Biomedical Research & Therapy 65
4.2.1 Gene Therapy 67
4.2.2 Drug Discovery 68
4.2.3 Diagnostics 69
4.2.4 Other Biomedical Applications 70
4.3 Agriculture 71
4.4 Industrial Use 72
4.5 Other Applications 73
5 Segmentation of North America Market by End User 74
5.1 Market Overview by End User 74
5.2 Pharmaceutical Companies 76
5.3 Biotechnology Companies 77
5.4 Academic Institutions & Research Centers 78
5.5 Other End Users 79
6 North America Market 2021-2031 by Country 80
6.1 Overview of North America Market 80
6.2 U.S. 83
6.3 Canada 86
6.4 Mexico 88
7 Competitive Landscape 89
7.1 Overview of Key Vendors 90
7.2 New Product Launch, Partnership, Investment, and M&A 94
7.3 Company Profiles 95
Abcam, Inc. 95
Agilent Technologies, Inc. 97
Applied StemCell, Inc. 98
Caribou Biosciences, Inc. 99
Cellecta, Inc. 100
CRISPR Therapeutics AG 101
Editas Medicine, Inc. 102
GeneCopoeia, Inc. 103
GeneScript Biotech Corporation 104
Horizon Discovery Group PLC 105
Integrated DNA Technologies, Inc. 106
Intellia Therapeutics Inc. 107
Lonza Group Ltd. 108
Merck KGaA 109
New England Biolabs, Inc. 110
Origene Technologies, Inc. 111
Rockland Immunochemicals, Inc. 112
Synthego Corporation 113
System Biosciences LLC 114
Takara Bio, Inc. 115
Thermo Fisher Scientific, Inc. 116
ToolGen, Inc. 117
RELATED REPORTS 118